← 홈

대장·직결장암

255개 · ADC 1068 · Antibody 5456 · CGT 2744 · 다음 갱신 D-13 · 마지막 7월 13일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 255개
AntibodystaleEli LillyPhase 1

Cetuximab + trifluridin tipiracil (Cetuximab + trifluridin tipiracil)

Colorectal Neoplasms Malignant · Colorectal Neoplasms Malignant

#ColorectalNeoplasmsMalignant#Antibody#Phase1#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleEli LillyPhase 1

Cetuximab - Cohort Expansion (Cetuximab - Cohort Expansion)

Colorectal Cancer Metastatic; Squamous Cell Carcinoma of Head and Neck · Colorectal Cancer Metastatic

#ColorectalCancerMetastatic#Antibody#Phase1#항체#면역항체+3
임상시험 1상태 RECRUITING
AntibodystaleEli LillyPhase 1

Cetuximab - Dose Escalation (Cetuximab - Dose Escalation)

Colorectal Cancer Metastatic; Squamous Cell Carcinoma of Head and Neck · Colorectal Cancer Metastatic

#ColorectalCancerMetastatic#Antibody#Phase1#항체#면역항체+3
임상시험 1상태 RECRUITING
AntibodystaleEli LillyPreclinical

trastuzumab (Herceptin, Cetuximab Ab; Bevacizumab; Vermofenib + cetuximab;Trastuzumab+lapatinib or trastuzumab+pertuzumab; others)

Metastatic Colorectal Cancer · Metastatic Colorectal Cancer

#MetastaticColorectalCancer#Antibody#Preclinical#항체#면역항체+2
임상시험 1상태 RECRUITING
AntibodystaleEli LillyPreclinical

Cetuximab Dabrafenib Tislelizumab (Cetuximab Dabrafenib Tislelizumab)

Advanced Colorectal Cancer · Advanced Colorectal Cancer

#AdvancedColorectalCancer#Antibody#Preclinical#항체#면역항체+2
임상시험 1상태 RECRUITING
AntibodystaleEli LillyPhase 1

Cetuximab Injection [Erbitux] (Cetuximab Injection [Erbitux])

BRAF V600E-mutated /MSS Metastatic Colorectal Cancer; Vemurafenib (BRAFi) Plus Cetuximab (EGFRi) Combined With PD-1 Mon… · EGFR

#EGFR#Antibody#Phase1#항체#면역항체+5
임상시험 1상태 ACTIVE
AntibodystaleEli LillyPhase 2

Cetuximab and FOLFIRI (Cetuximab and FOLFIRI)

Colorectal Cancer; Liver Metastases · Colorectal Cancer

#ColorectalCancer#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 ACTIVE
AntibodystaleEli LillyPhase 2

Cetuximab and FOLFOX (Cetuximab and FOLFOX)

Colorectal Cancer; Liver Metastases · Colorectal Cancer

#ColorectalCancer#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 ACTIVE
AntibodystaleEli LillyPhase 3

Cetuximab wkly (Cetuximab wkly)

Metastatic Colorectal Cancer · Metastatic Colorectal Cancer

#MetastaticColorectalCancer#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleEli LillyPhase 2

Cetuximab β；Fruquintinib； (Cetuximab β；Fruquintinib；)

Colorectal Neoplasms; RAS · Colorectal Neoplasms

#ColorectalNeoplasms#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 RECRUITING
AntibodystaleEli LillyPhase 2

Cetuximab β；Fruquintinib；anti-PD1 antibody； (Cetuximab β；Fruquintinib；anti-PD1 antibody；)

Colorectal Neoplasms; RAS · Colorectal Neoplasms

#ColorectalNeoplasms#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 RECRUITING
AntibodystaleEli LillyPhase 2

Cetuximab β；Fruquintinib；anti-PD1/CTLA4 antibody (Cetuximab β；Fruquintinib；anti-PD1/CTLA4 antibody)

Colorectal Neoplasms; RAS · Colorectal Neoplasms

#ColorectalNeoplasms#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 RECRUITING
AntibodystaleEli LillyPhase 2

Cetuximab, Irinotecan, Capecitabine (Cetuximab, Irinotecan, Capecitabine)

Rectal Neoplasms; Neoadjuvant Treatment · Rectal Neoplasms

#RectalNeoplasms#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 ACTIVE
AntibodystaleEli LillyPhase 2

Cetuximab, Oxaliplatin, Leucovorin, 5FU, Irinotecan (Cetuximab, Oxaliplatin, Leucovorin, 5FU, Irinotecan)

Metastatic Colorectal Cancer · Metastatic Colorectal Cancer

#MetastaticColorectalCancer#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleEli LillyPhase 1

Cetuximab/Gefitinib combination and/or monotherapy (Cetuximab/Gefitinib combination and/or monotherapy)

Colorectal Cancer; Head and Neck Cancer · Colorectal Cancer

#ColorectalCancer#Antibody#Phase1#항체#면역항체+3
임상시험 1상태 ACTIVE
AntibodystaleRochePreclinical

Chidamide, Tucidinostat; PD-1/PD-L1 inhibitor or double antibodies; Bevacizumab or tyrosine kinase inhibitors (Chidamide, Tucidinostat; PD-1/PD-L1 inhibitor or double antibodies; Bevacizumab or tyrosine kinase inhibitors)

Colorectal Cancer Metastatic · PD-1

#PD-1#Antibody#Preclinical#항체#면역항체+3
임상시험 1상태 RECRUITING
CGTBiologicstaleThe Affiliated Hospital of Qing…Preclinical

Chimeric antigen receptor T cell preparation targeting GCC (Chimeric antigen receptor T cell preparation targeting GCC)

Colon Cancer · Colon Cancer

#ColonCancer#CGT#Preclinical#세포유전치료#CAR-T+2
임상시험 1상태 ACTIVE
AntibodystaleHoffmann-La RochePhase 1

Cibisatamab (Cibisatamab)

Colorectal Cancer · Colorectal Cancer

#ColorectalCancer#Antibody#Phase1#항체#면역항체+2
임상시험 1상태 DISCONTINUED
AntibodystaleChinese PLA General HospitalPhase 2

Colorectal cancer: Tunlametinib + cetuximab β (Colorectal cancer: Tunlametinib + cetuximab β)

Treatment for Advanced Colorectal Cancer; Treatment for Advanced Pancreatic Cancer · Treatment for Advanced Colorectal Cancer

#TreatmentforAdvancedColorectalCa#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 RECRUITING
AntibodystaleFudan UniversityPreclinical

DEBIRI Combined With Chemotherapy and Bevacizumab (DEBIRI Combined With Chemotherapy and Bevacizumab)

Colorectal Neoplasms · Colorectal Neoplasms

#ColorectalNeoplasms#Antibody#Preclinical#항체#면역항체+2
임상시험 1상태 ACTIVE

7 / 13 페이지

← 이전다음 →